|
Tackle Ambiguities Upfront in Emergency Research
Sponsors seeking to conduct emergency research under the FDA regulation that allows a waiver of informed consent, or a parallel waiver to the Common Rule issued by the HHS secretary, should address a host of difficult ethical issues and ambiguities while developing the trial protocol, according to an expert. This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives